
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TMEM205 CRISPR/Cas9 KO Plasmid (m) | sc-433421 | 20 µg | $397.00 |
Tmem205 encodes TMEM205, a multi-pass membrane protein implicated in cellular transport processes at the plasma membrane and endomembrane system, with reported roles in regulating intracellular accumulation and efflux of xenobiotics and metal-containing compounds. TMEM205 has been linked to stress-adaptive remodeling of membrane trafficking and vesicular transport, processes that intersect with proteostasis and cellular response to cytotoxic insults. Altered TMEM205 expression has been associated with drug response phenotypes in cancer models, making it a useful target for dissecting mechanisms of chemoresistance and membrane transport regulation. In mouse systems, Tmem205 perturbation can help clarify how transporter-like membrane proteins influence cellular homeostasis and sensitivity to environmental challenges.
TMEM205 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tmem205 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tmem205 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tmem205 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TMEM205 protein expression.
This CRISPR knockout system enables efficient generation of Tmem205-deficient cell models for investigation of TMEM205 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.